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Memory deficits in aging affect millions of people and
are often disturbing to those concerned. Dissection of the
molecular control of learning and memory is paramount to
understand and possibly enhance cognitive functions. Old-
age memory loss also has been recently linked to altered
Ca2+ homeostasis. We have previously identified DREAM
(downstream regulatory element antagonistic modulator),
a member of the neuronal Ca2+ sensor superfamily of EF-
hand proteins, with specific roles in different cell compart-
ments [1, 2]. In the nucleus, DREAM is a Ca2+-dependent
transcriptional repressor, binding to specific DNA signa-
tures [1, 3], or interacting with nucleoproteins regulating
their transcriptional properties [4–6]. Also, we and others
have shown that dream mutant (dream2/2) mice exhibit
marked analgesia [7, 8]. Here we report that dream2/2 mice
exhibit markedly enhanced learning and synaptic plasticity
related to improved cognition. Mechanistically, DREAM func-
tions as a negative regulator of the key memory factor CREB
in a Ca2+-dependent manner, and loss of DREAM facilitates
CREB-dependent transcription during learning. Intriguingly,
18-month-old dream2/2 mice display learning and memory
capacities similar to young mice. Moreover, loss of DREAM
protects from brain degeneration in aging. These data iden-
tify the Ca2+-regulated ‘‘pain gene’’ DREAM as a novel key
regulator of memory and brain aging.
Results and Discussion
Although early studies with dream2/2 mice did not find cogni-
tive impairment via the Morris water maze task [7], electro-
physiological analysis in hippocampal slices showed that
dream mutant mice exhibit enhanced long-term synaptic effi-
cacy (LTP) [8], electrophysiological changes implicated in
learning and memory [9, 10], suggesting that dream2/2 mice
may exhibit some alterations in learning and memory. To test
this hypothesis, we submitted dream mutant mice to more
*Correspondence: josef.penninger@imba.oeaw.ac.at (J.M.P.), amancar@
upo.es (A´.M.C.)stringent tasks to evaluate learning and memory enhancement.
The object recognition (OR) memory test is a one-trial model of
learning and memory involving the perirhinal cortex and hippo-
campus [11, 12]. When dream2/2 and wild-type littermate mice
received a 15 min training session, no differences were
observed in short-term memory (STM) assessed 1 hr after
training nor in long-term memory (LTM) assayed 24 hr after
training (Figure 1A). Intriguingly, with shortened training
session, dream2/2 mice exhibited remarkably increased STM
as well as significantly enhanced LTM (Figure 1A). The explora-
tion times in short and long training protocols for the OR
memory test were comparable between dream2/2 and wild-
type control mice (Table S1 available online). To extend our
results to associative learning, we performed trace eyeblink
classical conditioning (EBCC), a hippocampal-dependent
task, and fixed-interval operant conditioning tests [13], a non-
hippocampal-dependent learning test. In both conditioning
paradigms, dream2/2 mice learned the two tasks significantly
faster than did wild-type mice (Figures 1B and 1C). We further
tested information consolidation 10 days after the last learning
session in trace EBCC. Wild-type mice showed lower retention
indexes than did dream2/2 mice (Figure 1B), indicating that
loss of DREAM leads to prolonged memory functions.
We next performed learning paradigms related to novel taste
food intake [14] because it permits the study of different
aspects of learning and memory processes, including erasure.
Whereas first exposure to the new taste was characterized by
neophobia in both mutant and control mice, food intake was
nearly doubled at the second access in wild-type and
dream2/2 mice (Figure 1D). Another attribute of taste learning
is the ability to form aversions when novel taste is paired with
a malaise-inducing agent (LiCl). Intakes of the novel taste
were significantly suppressed after a single LiCl administration
in dream2/2 mice relative to wild-type mice (Figure 1E). Only
after a second LiCl administration was the aversion to the novel
taste intake similar between wild-type and dream2/2 mice.
Finally, we assessed the time required to forget the novel
taste-LiCl association. Intriguingly, whereas wild-type mice
already forgot the adverse stimulus 3 days after aversion acqui-
sition, dream2/2 mice required 10 days to forget the novel
taste-LiCl association (Figure 1F). These data show that loss
of DREAM expression results in a marked and generalized
improvement in learning and memory controlled by different
neuronal circuits.
DREAM is expressed in the hippocampus [1], a brain area
involved in learning and memory consolidation [15]. To study
hippocampal electrophysiology in dream2/2 mice, we im-
planted stimulating electrodes into Schaffer’s collaterals and
a recording electrode in apical dendrites of the CA1 field (Fig-
ure 2A). The analysis of basal synaptic transmission by paired-
pulse facilitation (PPF), a short-term enhancement of gluta-
mate synaptic efficacy, with interpulse intervals from 50 to
200 ms did not show any differences between wild-type and
dream2/2 mice (Figure 2B). We next examined the role of
DREAM in LTP of synaptic transmission evoked in the CA3-
CA1 synapse in behaving mice. When we used a single or three
high-frequency stimulation protocols (HFS, consisting of
five trains at 200 Hz, lasting 100 ms, and presented at a rate
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55of 1/s), only short-term changes in synaptic efficacy were
detected in wild-type mice (Figures 2C and 2D). However, the
same stimulation protocols produced a sustained response in
dream2/2 mice (Figures 2C and 2D). Importantly, in the
dream2/2 mice, even a single HFS train was sufficient to
produce an overall LTP that was similar to that produced by
six HFS trains in dream2/2 or wild-type mice (Figure 2E). These
results indicate that long-term synaptic plasticity evoked by
HFS trains is facilitated in dream2/2 mice.
Prolonged changes in synaptic efficacy and memory involve
nuclear-dependent processes [16, 17]. Administration of ani-
somycin, a potent protein synthesis inhibitor, before a HFS
and a 5 min OR memory training session in dream2/2 mice
reduced the lasting LTP (L-LTP) induced by one HFS train
and LTM facilitation, without alterations in early LTP (E-LTP;
Figure S1). Thus, learning and E-LTP facilitation in dream2/2
mice appear to be independent of protein synthesis, but
enhancement in memory consolidation and L-LTP requires
de novo protein synthesis. DREAM is a transcriptional
repressor that is bound to the DRE site [1, 3, 4]. DREAM-
dependent transcription occurs by removal of DREAM from
DRE sequences. We therefore wanted to assess whether
Figure 1. Enhancement of Learning and Memory in dream2/2 Mice
(A) The OR memory test was performed in dream mutant and control
wild-type (WT) mice after 5 and 15 min training sessions. Discrimina-
tion indices calculated as [tnovel 2 tfamiliar]/[ tnovel + tfamiliar] during
training; short-term memory (STM) and long-term memory (LTM)
(1 and 24 hr after training, respectively) are shown. n = 8 for each
group.
(B) Percent of responses per session across the whole training, via
a trace electrical shock-SHOCK eyeblink classical conditioning
paradigm. H, habituated session. Numbers on x axis indicate
different conditioning sessions. Recall sessions (R) were performed
10 days after the last conditioning session. n = 8 for each group.
(C) Number of conditioning responses per session with 12 s fixed-
interval operant conditioning training. n = 10 for the two groups.
(D–F) Number of grams of coconut bar intake in each session of taste
neophobia (D), taste aversion acquisition (E), and the forgetting
phase (F). Syringe indicates LiCl administration. n = 8 for both
groups.
In all panels, white and gray colors represent wild-type (WT) and
dream2/2 littermate mice, respectively. All data are shown as
mean values 6 SEM. Plus sign indicates statistical significance of
the difference between wild-type and dream2/2 mice in the same
session; asterisk indicates statistically significant differences
between each session with respect to the first session in the same
experimental group. Single plus sign or asterisk indicates p %
0.05; two plus signs or asterisks indicates p % 0.01; and three
plus signs or asterisks indicates p% 0.001.
training for OR memory affects DREAM binding to DRE
sites in the mouse hippocampus. Nuclear extracts
from the hippocampus gave a band in electrophoretic
mobility shift assays (EMSA) that could be supershifted
by an DREAM antibody and was absent in nuclear
extracts from dream2/2 mice (Figure 3A). To study the
effect of different training times for OR memory on
DREAM activity, nuclear extracts were prepared from
the hippocampus of wild-type mice 30 min after habitu-
ation (untrained) and after 5 or 15 min OR training
sessions. Interestingly, animals trained for 15 min
showed a marked reduction in DREAM binding activity
to DRE sequences in the hippocampus nuclear extracts
as compared to untrained mice. DREAM protein levels in
the nuclear extracts did not change over the time course
studied (Figure 3B). These results show that synaptic activity
induced by learning modulates DREAM activity.
It has been reported that DREAM interacts with CREB [5],
a pivotal transcription factor involved in memory [16, 17].
CREB binds to cAMP-response element sequences (CRE
site) [18]. To attain full transcriptional activity, CREB interacts
with the histone acetyl transferase enzyme CBP dependent on
Ser-133 phosphorylation [19]. In vitro, unphosphorylated
CREB interacts with DREAM to abolish CREB-CBP interaction
in a Ca2+- and PKA-dependent manner [5] (Figure S2). To study
the DREAM-CREB-CBP interaction in vivo during OR memory,
we performed EMSA with nuclear extracts collected from
hippocampi of wild-type and dream2/2 mice 30 min after
different OR training session times in the presence or absence
of antibodies against CREB, phospho-CREB (P-CREB),
DREAM, and CBP (Figure 3C). In untrained and 5 min-trained
wild-type mice, CREB interacted with DREAM as shown by
a supershifted band in the presence of the DREAM antibody.
A 15 min training provoked CREB phosphorylation and CBP
recruitment whereas the association between DREAM and
CREB was lost (Figure 3C). In dream2/2 mice, the same assay
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(A) Schematic representation of sites where the stimulating and recording
electrodes, aimed to activate CA3-CA1 synapses in the hippocampus,
were implanted.
(B) Basal neurotransmission was measured by paired pulses with interpulse
intervals from 50 ms to 200 ms. The percentage of paired-pulse facilitation
(PPF) was calculated as (slope S2/slope S1) 3 100.
(C and D) Changes in the slope of EPSPf provoked by single (C) and three (D)
high-frequency stimulations (HFS, five trains [200 Hz, 100 ms] of pulses at a
rate of 1/s). Note that the evoked L-LTP lasted for up to 2 hr in dream2/2
mice (gray), but not in wild-type (WT) littermates (white).
(E) Six HFS trains induced L-LTP (lasting more than 2 hr) in wild-type and
dream2/2 mice. n = 6 for each group.
All data are shown as mean values 6 SEM. Plus sign indicates statistically
significant difference between wild-type and dream2/2 mice at different
times after HFS; asterisk indicates statistically significant differences at 5,showed that in untrained animals, the specific band for the
CRE site is formed by CREB; importantly, CREB phosphoryla-
tion and CBP recruitment to CREB required only 5 min of
training (Figure 3C). These biochemical data show that loss
of DREAM expression lowers the threshold for CREB phos-
phorylation and CREB-CBP interactions in OR learning.
To further address the functionality of CREB-DREAM-CBP
interactions in learning and memory, we crossed a CRE-lacZ
transgene [20], where the lacZ reporter is expressed under
the control of a CREB-dependent promoter, onto a dream
mutant background to generate CRE-lacZ+/2 dream2/2 mice.
First, we studied lacZ mRNA expression in the hippocampus
of CRE-lacZ+/2 dream+/+ and CRE-lacZ+/2 dream2/2 mice
after different new environment exploration times. Expression
of lacZ in a DREAM wild-type background was detected only
when mice were submitted to 15 min of exploration
(Figure 3D). In the dream mutant background, we detected
high levels of lacZ mRNA already after 5 min of exploring the
new environment (Figure 3D). These results confirmed that
already a short-term exploration stimulus can trigger CREB-
regulated transcription in dream2/2 mice. We next assayed
whether the CREB-regulated immediate early genes c-fos,
bdnf, and c-jun, which have been previously implicated in
long-term synaptic plasticity [21–24], were also induced by
5 min training in dream2/2 mice. Semiquantitative RT-PCR to
study the levels of mRNA for c-fos and bdnf (Figure 3D) and
immunohistochemistry to examine c-Fos and c-Jun protein
(Figure 3E) revealed that wild-type mice required 15 min of
training to reach a robust increase of c-fos, bdnf, and c-jun
mRNA and protein expression in the hippocampus. In
dream2/2 mice, 5 min of training was sufficient to trigger
robust c-fos, bdnf, and c-jun expression in the hippocampus
(Figures 3E and 3F). These data indicate that DREAM functions
as a negative regulator of CREB-dependent transcription and
that DREAM sets the threshold for CREB activation in learning
and memory.
Adult (6-month-old) dream2/2mice exhibit marked improve-
ments in cognitive capacities. Because learning and memory
deficits are common in aging, we wanted to test whether
DREAM might also confer improved cognition in aged mice
(18 months old). With a 15 min training session for OR memory,
only aged dream2/2 mice remembered the information both
1 hr and 24 hr after training, reflecting STM and LTM (Fig-
ure 4A). The exploration times in each session of the OR
memory test were not different between aged wild-type and
dream2/2 mice (Table S2). Thus, loss of DREAM not only
improves learning and memory in young mice but also confers
improved cognition in old age.
At the cellular level, deficiencies in learning and memory
processes in aged mice correlate with morphological and
functional changes in the hippocampus [25, 26]. Normal aging
process in wild-type mice results in a decrease in the hippo-
campus:brain area ratio characterized by loss of NeuN-posi-
tive neurons and reduced expression of synaptic proteins
such as MAP2 and synaptophisin (Figures 4B and 4C). Further-
more, aging results in impaired glutamatergic neuronal trans-
mission as indicated by reduced expression of NMDA recep-
tors (Figure 4C). As reported previously [27], aging mice also
develop gliosis as detected by an increase in GFAP-express-
ing astrocytes (Figure 4D) and the expansion of cd11b-positive
30, 60, and 120 min after HFS with respect to baseline values in the same
group. Single plus sign or asterisk indicates p % 0.05; two plus signs or
asterisks indicates p% 0.01.
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(A) DREAM DNA-binding activity is modulated by recognition memory training. Values are compared with those of untrained animals (100% activity). n = 3
mice per group.
(B) Western blot for CBP, CREB, and DREAM in nuclear hippocampal extracts collected from untrained wild-type (WT) and dream2/2 mice and 30 min after
5 or 15 min of training. As internal control, b-Actin is shown.
(C) Composition of CRE-binding complexes in hippocampal nuclear extracts of untrained WT and dream2/2 mice and extracts obtained 30 min after 5 and
15 min OR memory training sessions. Complexes were assayed by supershift with the indicated antibodies. > indicates specific DNA-binding complexes
and SS indicates supershift DNA-binding complexes. Data are representative of three different experiments with similar results.
(D) Semiquantitative RT-PCR analyses of lacZ, c-fos, and bdnf mRNA from hippocampus of untrained and 5 and 15 min OR-trained CRE-lacZ+/2 dream+/+
and CRE-lacZ+/2 dream2/2 mice. gapdh mRNA served as internal control. Values illustrate the densitometric quantification of lacZ, c-fos, and bdnf gene
expression in each experimental group with respect to untrained animals at time point zero (0). n = 5 mice per group.
(E) c-Fos and c-Jun protein expression in hippocampi of untrained (time point 0) WT and dream2/2 mice and mice submitted to 5 or 15 min OR training.
Representative micrographs are shown. Magnifications 320. n = 5 mice per group. Data are shown as mean values 6 SEM of c-Fos-positive cells/
100 mm2 in the hippocampal CA1 field or c-Jun densitometric quantification of the hippocampal CA1 region and dentate gyrate, respectively. Asterisk indi-
cates statistical significance comparing trained and untrained groups within the same genetic cohort. *p% 0.05; **p% 0.01.microglia cells (Figure 4E). Importantly, all of these age-related
changes in the hippocampus did not occur in 18-month-old
dream2/2 mice (Figures 4B–4E). Of note, dream mutant mice
showed increased GFAP immunoreactivity at a younger age,
but this did not change during aging (Figure 4D). Thus, loss
of DREAM expression not only allows for improved cognition
but also markedly slows ‘‘brain aging.’’
Our results demonstrate that DREAM is a modulator of
neuronal plasticity that determines the stimulation threshold
required for establishing long-term changes in synaptic
efficacy. DREAM DNA binding activity, as well as interaction
with CREB, is regulated by synaptic activity induced by explor-
atory training. Importantly, in dream2/2 mice, even short-term
synaptic activity is sufficient to trigger CREB-dependent gene
expression required for LTP and memory. Moreover, dream2/2
mice did not show neuronal degeneration and cognitive
deficiencies associated with aging. Mice that express a consti-
tutive active CREB [28] develop extensive neurodegeneration,
so these findings suggest that DREAM might control additional
transcriptional programs and possibly nontranscriptionaltargets to regulate survival and maintenance of neurons in
the aging brain. Recent data suggest that Ca2+ leakage might
be an important feature of neurodegeneration and memory
loss in old age [29]. For instance, presenilin1 and 2 have been
proposed to form low-conductance Ca2+ leak channels, a func-
tion disrupted by familial Alzheimer’s disease-linked mutations
[30]. DREAM functions are regulated by Ca2+, so reduced Ca2+
flux in old-age dementia could result in enhanced DREAM
activities whereas Ca2+ signals might reduce DREAM functions
and thereby improve cognition and brain aging.
This study for the first time identifies a transcriptional
repressor that is critically involved in long-term hippo-
campal-dependent synaptic potentiation and memory forma-
tion in mice. Mechanistically, DREAM controls CREB-depen-
dent transcriptional activity, thereby directly coupling to
a central regulator of cognition. Intriguingly, loss of DREAM
also results in improved memory functions in old age and
slows hippocampal brain aging. DREAM is also a central regu-
lator of pain perception [7], and chronic pain has been known
for long time to worsen memory and learning in humans [31,
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(A) The OR memory test was performed in 18-month-old control wild-type (WT) and dream2/2 mice after 15 min training sessions. Discrimination indices
during training, short-term memory (STM; 1 hr after training), and long-term memory (LTM; 24 hr after training) are shown. n = 8 for both groups.
(B) Hippocampus:brain area ratios in 6- and 18-month-old WT and dream2/2 mice. n = 8 mice per group. Areas were determined with ImageJ software.
(C) Expression of the general neuronal marker NeuN (determined by immunohistochemistry) and map2, synaptophisin, and nmda-r1 (assessed by
semiquantitative RT-PCR) in hippocampi collected from 6- (white bars) and 18- (black bars) month-old WT and dream2/2 mice. n = 6 animals per group.
(D and E) Lack of age-dependent hippocampal gliosis in 6- and 18-month-old dream2/2 mice.
(D) Control WT and dream2/2 mice were assayed for GFAP protein via immunoreactivity.
(E) cd11b mRNA expression was detected by semiquantitative RT-PCR.
In all panels, mean values 6 SEM are shown. *p% 0.05; **p% 0.01; ***p% 0.001.32], so DREAM could be a missing link between pain
responses and cognition. Thus, DREAM could be a potential
new target to not only reduce pain but also to increase cogni-




Both dream mutant mice and CRE-lacZ transgenic mice have been previ-
ously described [7, 20]. dream2/2 CRE-lacZ mice were generated by inter-
breeding and crossed onto a C57Bl/6 background. All behavioral and elec-
trophysiological studies were performed with male mice conducted in
accordance with the guidelines of the European Union Council (86/609/
EU) and according to Spanish regulations for the use of laboratory animalsin chronic experiments (BOE 67/8509-12, 1988). All experiments were
approved by the institutional animal care committee.
Behavioral Assays
The OR memory test, fixed operant conditioning, trace eyeblink classical
conditioning, and taste aversion conditioning were performed as described
[13]. Taste aversion conditioning was performed as described in [14]. We
also included a forgetting test, where different cohorts were exposed for
10 min to a coconut bar in the absence of a malaise-inducing agent (LiCl)
at different times (3, 4, 5, or 10 days) after aversion acquisition. Details on
behavioral tests are described in the Supplemental Data.
Electrophysiology
Surgery and free-moving mice electrophysiological recordings were per-
formed as described [10, 13] and described in detail in the Supplemental
Data.
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For immunohistochemistry (IHQ), antibodies against c-Fos (sc-52, Santa
Cruz), c-Jun (sc-45, Santa Cruz), the specific neuronal-specific nuclear
protein NeuN (Chemicon, Temecula, CA), and glial fibrillary acidic protein
(GFAP; DakoCytomation, Carpinteria, CA) were used. All antisera were
used at 1:1000 dilutions. In all of the cases, antibody staining was developed
with H2O2 and diaminobenzidine. Tissue sections were examined with dark-
field microscopy. To minimize variability, at least five sections per animal
were analyzed with a bright-field DMRB RFY HC microscope (Leica, Ben-
sheim, Germany). For IHQ quantification, sections corresponding to stereo-
taxic coordinates 21.34 mm to22.80 mm with respect to the Bregma were
analyzed. The hippocampus:brain ratio was analyzed as described [33].
Electrophoretic Mobility Shifts
Nuclear extracts were prepared as described [34]. Double-stranded oligo-
nucleotide probes corresponding to human DRE (downstream regulatory
element) (50-GAAGCCGGAGTCAAGGAGGCCCCTG-30) or CRE (cAMP-
response element) (50-CTTGGCTGACGTCAGAGA-30) were labeled with
[g-32P]ATP. Nuclear proteins (5–10 mg) were mixed with specific antibodies
against CREB (X-12, Santa Cruz), phospho-CREB (New England Biolabs),
CBP (A-22, Santa Cruz), or DREAM (FL-214, Santa Cruz) for 12 hr at 4C
followed by incubation with the radioactive-labeled probes. Protein-DNA
complexes were resolved in 5% nondenaturing polyacrylamide gels and
visualized by autoradiography.
mRNA Analysis by Reverse Transcription-PCR
Total RNA from brain tissue was extracted with Tripure reagent (Roche
Products, Hertfordshire, UK). A minimum of six animals per group, collected
from at least two different experimental sessions, were used for each exper-
iment. Detailed primer information can be found in Supplemental Experi-
mental Procedures. Arbitrary units were calculated and compared to gapdh
expression.
Statistical Analyses
The results were processed for statistical analysis with the SPSS for
Windows package (SPSS, Chicago, IL). Unless otherwise stated, data are
represented as mean values 6 SEM. Data were analyzed with one-way and
two-way ANOVA tests. The Tukey test was used for post hoc comparisons.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures, two
figures, and two tables and can be found with this article online at http://
www.current-biology.com/supplemental/S0960-9822(08)01614-X.
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